Lumida
/SLP
⌘K
Simulations Plus Inc

Simulations Plus Inc

SLP
$18.42USD↑+0.00%+0.00 today

MARKET CAP

372.5M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$18 – $18

52W RANGE

$11
$21

AI Summary

Stalk
StalkMedium

SLP remains in an early Stage 1 basing regime with a higher low and repaired 9/21 EMA support, but price is stalled near 200DMA resistance and extreme overbought levels. Without a clear breakout or active pattern, the medium-term bias is cautiously bullish on the basing structure, yet short-term timing is unfavorable amid RSI exhaustion and a mild rejection. We defer execution, waiting for a pullback into the 9/21 EMA zone or lower range support before considering entry.

  • ↑Acquisition by Altaris at $18.50 implies 26% premium over trading price
  • ↑Q3 revenue $21.9 M (+7% YoY) and adjusted EBITDA margin at 36%
  • ↓Software revenue flat and F4Q:25 software sales down 6% YoY
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Simulations Plus, Inc. (NASDAQ: SLP) is an emerging leader in the healthcare technology sector focused on drug discovery and development software that harnesses artificial intelligence and machine learning. Positioned within the broader theme of digital transformation in healthcare, SLP develops innovative solutions essential for advancing pharmaceutical research and improving drug development efficiencies. With its commitment to research-driven software solutions, SLP highlights its niche status as a valuable player in a growing market.

Bull says

  • ↑Acquisition by Altaris at $18.50 implies 26% premium over trading price
  • ↑Q3 revenue $21.9 M (+7% YoY) and adjusted EBITDA margin at 36%
  • ↑Backlog up 30% YoY signals robust demand for SLP's solutions
  • ↑Strong liquidity score (1.14) and $18.4 M free cash flow support flexibility
  • ↑Dividend yield of 0.31% underlines disciplined capital returns
  • ↑High book-to-price ratio and positive dividend factor suggest undervaluation

Bear says

  • ↓Software revenue flat and F4Q:25 software sales down 6% YoY
  • ↓Negative earnings yield and profitability scores point to weak returns
  • ↓Volatility score at 2.28 indicates elevated price swings
  • ↓Majority of analysts rate stock 'Reduce' with lower price targets
  • ↓Low size and quality factors suggest limited financial stability
  • ↓Stagnating organic growth amid competitive AI software landscape

Earnings Call · Q4 2024 · Mgmt. Guidance

Updated 12-02-2025neutral

Transcript signals

Bull points

  • Total revenue increased 19% to $18.7 million, including a $2.3 million contribution from Proficiency.
  • Fiscal year total revenue increased 18% to $70 million.
  • our software customer renewal rate was 93% based on fees and 84% based on accounts, both increasing slightly compared to the prior year.

Bear points

  • Loss from operations was negative 6% of revenue compared to negative 2% last year,
  • adjusted diluted EPS excluding the impact of transaction related costs were 53 cents compared to 67 cents last year. Adjusted diluted EPS was lower than expected, primarily due to the lower transaction related expense add back to diluted EPS in the fourth quarter.
  • adjusted diluted EPS, excluding the impact of transaction-related costs, were 53 cents compared to 67 cents last year. Adjusted diluted EPS was lower than expected, primarily due to the lower transaction related expense add back to diluted EPS in the fourth quarter.
Read full transcript analysis ›